EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark APTAH was filed as Word mark on 03/11/2022 at the European Union Intellectual Property Office.
It was registered as a trademark on 08/11/2022.
The current status of the mark is "Trademark registered".
| Trademark form | Word mark |
| File reference | 018670606 |
| Application date | March 11, 2022 |
| Publication date | May 4, 2022 |
| Entry date | August 11, 2022 |
| Expiration date | March 11, 2032 |
Trademark owner
930 Brittan Ave.
94070 San Carlos
US
94070 San Carlos
US
Trademark representatives
Leopoldstr. 4
80802 München
DE
goods and services
1
Biomolecules for medical and scientific research
5
Pharmaceutical preparations for the configuration, modulation and correction of rna transcript splicing and other post-transcription processes; pharmaceutical preparations for the configuration, modulation and correction of rna for the treatment of genetic diseases; pharmaceutical preparations for restoring and reprograming rna-protein interactions for the treatment of diseases; pharmaceutical preparations for the treatment of diseases associated with gene dysregulation, inhibition or suppression of gene expression; pharmaceutical preparations for the treatment of genetic diseases; gene therapy products, namely, molecules for controlling gene expression; molecular diagnostic tests for testing bodily fluid for the detection of diseases; medical diagnostic tests for the detection of neurodegenerative, oncological and infectious diseases
42
Research and development of pharmaceuticals, namely, therapies for the configuration, modulation and correction of rna transcript splicing and other post-transcription processes; research and development of therapies in the fields of biotechnology, genetic medicine, gene therapy, dna, rna, molecules and proteins; design and development of biomolecules for medical and scientific use, and medical treatment; drug design and development featuring biomolecules
ID: 11018670606